Riverview Trust Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Riverview Trust Company's AMGN Position: Q2 2026 in Review
Riverview Trust Company held its Amgen (AMGN) position steady in Q2 2026 at 546 shares worth $198K. The position accounts for 0.24% of the portfolio, ranked #55.
Riverview Trust Company first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $336K in Q4 2019. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Riverview Trust Company held 546 shares of Amgen worth $198K as of Q2 2026.
- Riverview Trust Company left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.24% of Riverview Trust Company's portfolio in Q2 2026, its #55 holding.
- Riverview Trust Company first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Riverview Trust Company's Amgen position peaked at $336K in Q4 2019.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Riverview Trust Company's 13F filing for Q2 2026, filed 3 Aug 2026.